About

PMC's Annual Award for Leadership in Personalized Medicine

Jay Flatley, Executive Chairman, Illumina (right), accepts the 13th Annual Award for Leadership in Personalized Medicine from Paul R. Billings, M.D., Ph.D., Chairman, Biological Dynamics, at Harvard Medical School.

Nomination Period Now Closed

Thank you to all those who nominated a candidate for the 14th Annual Award for Leadership in Personalized Medicine. The award winner will share his or her vision for the future of personalized medicine at the 14th Annual Personalized Medicine Conference at Harvard Medical School from November 14 - 15, 2018.

The nomination period for the 15th Annual Award for Leadership in Personalized Medicine will open in March of 2019.

About the Award

The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.

Previous award recipients include:

• Jay T. Flatley (2017)
  Executive Chairman
  Illumina
  
• Raju Kucherlapati, Ph.D. (2016)
  Paul C. Cabot Professor of Genetics
  Harvard Medical School
  
• Francis S. Collins, M.D., Ph.D. (2015)
  Director
  National Institutes of Health (NIH)
  
• Mark Levin (2014)
  Co-founder, Partner
  Third Rock Ventures
  
• Kathy Giusti (2013)
  Founder, Chief Executive Officer
  Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  
• Randal W. Scott, Ph.D. (2012)
  Co-Founder
  InVitae Corporation
• Leroy Hood, Ph.D., M.D. (2011)
  President
  Institute for Systems Biology
• William S. Dalton, Ph.D., M.D. (2010)
  CEO
  M2GEN
  Director
  DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
• Brook Byers (2009)
  Managing Partner
  Kleiner Perkins Caufield & Byers (KPCB)
• Michael O. Leavitt (2008)
  Founder and Chairman
  Leavitt Partners
• Ralph Snyderman, M.D. (2007)
  Chancellor Emeritus
  Duke University
  Founder and Chairman
  Proventys, Inc.
  
• Elizabeth G. Nabel, M.D. (2006)
  President
  Brigham and Women's Health Care
• Janet Woodcock, M.D. (2005)
  Director
  FDA Center for Drug Evaluation and Research